🚀Harvard scientist founders with previous exits in excess of $8 billion

Click to rate this post!
[Total: 0 Your Rating: 0]

Developed at Mass General Hospital and Harvard University, C-Reveal’s proprietary technology helps the body’s immune system to identify and kill cancer cells. The company’s patent-pending discovery will make it easier to find and treat tumors and is expected to improve the efficacy of treatments for a broad range of cancers.

Deal Highlights:
Founded by Harvard scientists with previous exits in excess of $8 billion
Proprietary technology developed at Massachusetts General Hospital (MGH) and Harvard University
Experienced leadership team from AstraZeneca, MGH, Harvard Medical School, and Dana-Farber
$140 billion+ oncology market expected to reach more than $390 billion by 2027

This offering goes live next week. Reserve your shares now.


Join Our Newsletter



By Registering, you agree that you've read and accepted our disclaimer, you're at least 18 years old, you consent to the terms presented on the disclaimer, and to receive notifications from us.